These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1020864

  • 1. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M, Bouey P.
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract] [Full Text] [Related]

  • 2. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA.
    Encephale; 1973 Nov; 62(1):78-105. PubMed ID: 4718697
    [No Abstract] [Full Text] [Related]

  • 3. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM, Tétreault L, Elie R.
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J, Floreánová L, Polák L.
    Act Nerv Super (Praha); 1972 May; 14(2):97. PubMed ID: 5040183
    [No Abstract] [Full Text] [Related]

  • 10. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M, Mazaux JM, Imbert D, Daubech MJ, Daulouède JP, Tignol J.
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R, Gagnon MA, Gauthier R, Jéquier JC.
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract] [Full Text] [Related]

  • 12. Neurologic syndromes associated with antipsychotic-drug use.
    N Engl J Med; 1973 Jul 05; 289(1):20-3. PubMed ID: 4708951
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL.
    Dis Nerv Syst; 1976 Apr 05; 37(4):219-24. PubMed ID: 1253676
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM, Beckles D, Isalski Z, Lee JH.
    J Clin Pharmacol New Drugs; 1972 Apr 05; 12(4):142-52. PubMed ID: 4553448
    [No Abstract] [Full Text] [Related]

  • 16. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S, Buddeberg C.
    Nervenarzt; 1975 Oct 05; 46(10):589-90. PubMed ID: 811999
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J.
    Therapeutique; 1972 Nov 05; 48(9):561-8. PubMed ID: 4650525
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L.
    Mod Probl Pharmacopsychiatry; 1970 Nov 05; 5():50-4. PubMed ID: 5527168
    [No Abstract] [Full Text] [Related]

  • 20. Akathisia: a side effect to be remembered.
    Raskin DE.
    Am J Psychiatry; 1972 Sep 05; 129(3):345-7. PubMed ID: 5053718
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.